Log in

NASDAQ:OSMTOsmotica Pharmaceuticals Earnings Date, Estimates & History

$6.88
+0.20 (+2.99 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.79
Now: $6.88▼
$7.18
50-Day Range
$3.74
MA: $4.50▼
$6.68
52-Week Range
$2.30
Now: $6.88▼
$7.97
Volume318,398 shs
Average Volume347,093 shs
Market Capitalization$354.46 million
P/E RatioN/A
Dividend YieldN/A
Beta3.76

Earnings

Osmotica Pharmaceuticals (NASDAQ:OSMT) Earnings Information

Osmotica Pharmaceuticals last posted its earnings results on May 12th, 2020. The reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.07. The company had revenue of $48.65 million for the quarter, compared to analysts' expectations of $43.76 million. Osmotica Pharmaceuticals has generated $0.25 earnings per share over the last year. Osmotica Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Osmotica Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Osmotica Pharmaceuticals (NASDAQ:OSMT) Earnings Estimates

2020 EPS Consensus Estimate: ($0.74)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.18)($0.14)($0.16)
Q2 20202($0.19)($0.18)($0.19)
Q3 20202($0.24)($0.19)($0.22)
Q4 20203($0.26)($0.09)($0.18)

Osmotica Pharmaceuticals (NASDAQ OSMT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)		       
5/12/2020Q1 2020($0.12)($0.0458)($0.05)$43.76 million$48.65 millionTranscript
3/18/202012/31/2019$0.01($0.51)$0.63$53.88 million$59.91 millionTranscript
11/14/20199/30/2019($0.30)($2.15)$1.71$49.13 million$65.46 millionTranscript
8/8/2019Q2 2019($0.04)$0.02$2.41$57.90 million$57.53 millionTranscript
5/9/2019Q1 2019($0.04)($0.12)($0.12)$53.58 million$57.13 millionN/A
11/8/2018Q3 2018($4.99)($4.99)$66.35 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/6/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.